首页> 外文期刊>Human Genetics >Mutational analysis in longest known survivor of mucopolysaccharidosis type VII.
【24h】

Mutational analysis in longest known survivor of mucopolysaccharidosis type VII.

机译:在已知最长的粘多糖贮积症VII型幸存者中进行突变分析。

获取原文
获取原文并翻译 | 示例
       

摘要

Mucopolysaccharidosis VII (MPS VII) is an autosomal recessive disorder caused by the deficiency of beta-glucuronidase leading to the intralysosomal storage of heparan, dermatan, and chondroitin sulfate. Here, we report the identification of two novel missense mutations K350N and R577L in a 37-year-old patient with beta-glucuronidase deficiency and a relatively mild MPS VII phenotype. Expression of the K350N mutation in baby hamster kidney cells has revealed residual enzymatic activity and normal transport of the enzyme to the lysosome. However, expression of the R577L or the double mutant K350N/R577L results in rapid degradation of the enzyme in early biosynthetic compartments and a total loss of enzymatic activity. We attribute the mild phenotype to the residual catalytic activity provided by the K350N mutant. At the time of her death at the age of 37 years, this patient was the longest known survivor with MPS VII.
机译:粘多糖贮积症VII(MPS VII)是一种常染色体隐性遗传疾病,由β-葡萄糖醛酸苷酶的缺乏引起,导致肝素,皮肤素和硫酸软骨素的溶酶体储存。在这里,我们报告在一个37岁的β-葡萄糖醛酸苷酶缺乏症和相对较轻的MPS VII表型患者中鉴定了两个新的错义突变K350N和R577L。在婴儿仓鼠肾细胞中K350N突变的表达表明残留的酶活性和酶向溶酶体的正常转运。但是,R577L或双重突变体K350N / R577L的表达导致酶在早期生物合成区室中快速降解,并导致酶活性完全丧失。我们将轻度表型归因于K350N突变体提供的残留催化活性。在她37岁去世时,该患者是已知最长的MPS VII幸存者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号